Abbott to spin off the business behind Ensure, Similac and Pedialyte
Published
Abbott plans to split off its roughly $8.5 billion nutrition unit as a separate public company by the end of 2027. Abbott says the move lets it focus on medical devices and diagnostics.
Source: MedTech Dive
This is a plain-language summary. Read the original source for full details.